| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443137 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
L1CAM expression is a strong independent predictor for distant recurrence and overall survival in stage I endometrial cancer. These results warrant prospective validation of L1CAM as marker for selecting patients who could benefit from more extensive diagnostic and/or therapeutic procedures.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
T. Bosse, R.A. Nout, E. Stelloo, E. Dreef, H.W. Nijman, I.M. Jürgenliemk-Schulz, J.J. Jobsen, C.L. Creutzberg, V.T.H.B.M. Smit,